SC 13G Filing

Company

Vanda Pharmaceuticals Inc.

Filed

June 24, 2019

Accession Number

0000919574-19-004281

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →